Scott M Coiante's Net Worth
$1.04 Million
Who is Scott M Coiante?
Scott M Coiante has an estimated net worth of $1.04 Million. This is based on reported shares across multiple companies, which include AGILE THERAPEUTICS INC, and Aprea Therapeutics, Inc..
SEC CIK
Scott M Coiante's CIK is 0001608536
Past Insider Trading and Trends
2019 was Scott M Coiante's most active year for acquiring shares with 6 total transactions. Scott M Coiante's most active month to acquire stocks was the month of December. 2019 was Scott M Coiante's most active year for disposing of shares, totalling 2 transactions. Scott M Coiante's most active month to dispose stocks was the month of December. 2019 saw Scott M Coiante paying a total of $37,500.00 for 397,994 shares, this is the most they've acquired in one year. In 2021 Scott M Coiante cashed out on 7,534 shares for a total of $29,985.32, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGILE THERAPEUTICS INC (AGRX) Snapshot price: $1.6
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25,000.00% | 20K |
—
|
—
| 20.08K |
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +228.59% | 33.57K |
—
|
—
| 48.26K |
Jan 24 - Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +272.84% | 10.75K |
$3.32 | -$22,419.96 | 14.69K |
Jan 24 - Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aprea Therapeutics, Inc. (APRE) Snapshot price: $6.5
SVP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +72.15% | 60.8K |
—
|
—
| 145.06K |
Jul 28
| |||
Form 4
| -29.51% | -35.28K |
$0.81 | -$28,403.62 | 84.27K |
Jun 3
| |||
Form 4
| +55.97% | 42.9K |
—
|
—
| 119.55K |
Mar 10
| |||
Form 4
| -16.20% | -14.82K |
$1.74 | -$25,781.58 | 76.65K |
Feb 25
| |||
Form 4
| -7.61% | -7.53K |
$3.98 | -$29,985.32 | 91.47K |
Aug 25
| |||
Form 4
| +3,860.00% | 96.5K |
—
|
—
| 99K |
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 4
|
∞
| 2.5K |
$15.00 | $37,500.00 | 2.5K |
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||